Skip to main content
Signal8

Sullivan Eddie Joe

SEC insider (Form 3/4/5 filer). CIK 0001889712. PRESIDENT at SAB Biotherapeutics, Inc. (SABS). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in MIAMI BEACH, FL.

Companies Sullivan Eddie Joe has filed insider reports for

  • SAB Biotherapeutics, Inc. (SABS): Director, Officer, PRESIDENT
Sullivan Eddie Joe profile photo

Sullivan Eddie Joe

CIK: 0001889712

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SAB Biotherapeutics, Inc. logo
SABS

SAB Biotherapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Feb 3, 2026
    Award

    Stock option (right to buy)

    Direct
    3M shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Aug 26, 2025
    Award

    Stock Option (right to buy)

    Direct
    3M shares-

1-2 of 2